20/20 Biolabs, Inc. Common Stock (AIDX) is a Technology stock trading at $0.52 (as of 2026-07-23), with a market capitalization of $8.05M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Valuation — source: SEC EDGAR (first-party)
Price
$0.52
Market Cap
$8.05M
EV / EBITDA
-0.8
Price / Book
4.96
Price / Sales
3.94
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)
$2.05M
Net Margin
-182.8%
Return on Equity
-358.8%
Current Ratio
1.99
Revenue Growth (YoY)
36.5%
EPS Growth (YoY)
52.9%
Financial Health — source: SEC EDGAR
Altman Z-Score
-12.92 (distress)
Valuation vs Sector & Industry
Sector P/E (Technology)
31.8
Industry P/E (Business Services)
28.3
Company
Sector
Technology
Industry
Business Services
Related Companies (Business Services; 8 comparable business services companies)